This case study details the groundbreaking renewable natural gas (RNG) agreement between RTC Member AstraZeneca, a global biopharmaceutical company, and RTC Solutions Provider Vanguard Renewables. It provides an in-depth look at one of the largest business-to-business RNG purchases in the North American voluntary market, which will supply AstraZeneca with 650,000 MMBtu/year for 15+ years and contribute to the company’s ambition to reduce greenhouse gas emissions from its global operations (Scope 1 and 2) by 98% by 2026. Vanguard Renewables will build three new on-farm anaerobic digesters to produce the RNG.
Read this case study to understand the project’s origins, the decision-making process, and the collaborative efforts that led to its success. The case study offers valuable insights for others seeking to decarbonize their operations with renewable thermal solutions, especially RNG.
